Silicon Valley-based Amed Ventures is doubling down on Taiwan's Medtech  sector, launching a NTD 4 billion (approximately USD 125 million) fund to accelerate innovation in high-end  medical devices and contract development & manufacturing (CDMO). In November 2024, Wiltrom Co., Ltd. (6767.TWO)—Taiwan's first minimally  invasive spinal medical device company—secured NTD 270 million (approximately USD 8.4 million) in new  funding. The round was led by Amed Ventures, with participation from its major  shareholder, Intai Technology (4163.TWO).

William Tai, Managing Partner at Amed Ventures, emphasized that beyond financial backing, the firm plays an active strategic role, helping portfolio companies scale, innovate, and navigate global markets.

Learn more about Amed Ventures' Taiwan Medtech investments!

編輯推薦

• 矽谷Amed Ventures在臺啟動 第三支創投基金鏈結臺、美醫材市場
• 矽谷Amed Ventures基金挹注、政府政策加持 協力深化CDMO、智慧醫療、加速鏈結國際
• Amed Ventures助臺灣醫材串接美國生態系！ 將啟動第三支基金
• 矽谷Amed Ventures在臺啟動一億美元醫材創投基金 鏈結臺、美醫療市場